Radiomolecular Theranostics With Fibroblast-Activation-Protein Inhibitors and Peptides

被引：5

作者：

Baum, Richard P. ^{[1
,9
]}

Novruzov, Emil ^{[2
]}

Zhao, Tianzhi ^{[3
,4
,5
]}

Greifenstein, Lukas ^{[1
]}

Jakobsson, Vivianne ^{[3
,4
,5
]}

Perrone, Elisabetta ^{[6
]}

Mishra, Aditi ^{[1
]}

Eismant, Aleksandr ^{[1
]}

Ghai, Kriti

Klein, Ortwin ^{[7
]}

Jaeschke, Bastian ^{[7
]}

Benz-Zils, Daniel ^{[1
]}

Cardinale, Jens ^{[2
]}

Mori, Yuriko ^{[2
]}

Giesel, Frederik L. ^{[2
,8
]}

Zhang, Jingjing ^{[3
,4
,5
]}

机构：

[1] DKD HELIOS Klin, Ctr Adv Radiomol Precis Oncol, Dept Nucl Med, Curanosticum Wiesbaden Frankfurt, Wiesbaden, Germany

[2] Heinrich Heine Univ, Univ Hosp Dusseldorf, Med Fac, Dept Nucl Med, Dusseldorf, Germany

[3] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Diagnost Radiol, Singapore, Singapore

[4] Natl Univ Singapore, Clin Imaging Res Ctr, Ctr Translat Med, Yong Loo Lin Sch Med, Singapore, Singapore

[5] Natl Univ Singapore, Yong Loo Lin Sch Med, Nanomed Translat Res Program, Singapore, Singapore

[6] Univ Cattolica Sacro Cuore, Inst Nucl Med, Dept Radiol & Hematol Sci, Rome, Italy

[7] Helios DKD Klin, Dept Oncol MVZ, Wiesbaden, Germany

[8] Osaka Univ, Inst Radiat Sci, Osaka, Japan

[9] DKD HELIOS Klin Wiesbaden, Ctr Adv Radiomol Precis Oncol, Aukammallee 33, D-65191 Wiesbaden, Germany

来源：

SEMINARS IN NUCLEAR MEDICINE | 2024年 / 54卷 / 04期

关键词：

TUMOR PROGRESSION; PHASE-I; CANCER; EXPERIENCE; THERAPY; PET/CT; EXPRESSION; TRACERS; BREAST;

D O I：

10.1053/j.semnuclmed.2024.05.010

中图分类号：

R8 [特种医学]; R445 [影像诊断学];

学科分类号：

1002 ; 100207 ; 1009 ;

摘要：

The advancement of theranostics, which combines therapeutic and diagnostic capabilities in oncology, has significantly impacted cancer management. This review explores fibroblast activation protein (FAP) expression in the tumor microenvironment (TME) and its association with various malignancies, highlighting its potential as a theranostic marker for PET/CT imaging using FAP-targeted tracers and for FAP-targeted radiopharmaceutical therapy. We examine the development and clinical applications of FAP inhibitors (FAPIs) and peptides, providing insights into their diagnostic accuracy, initial therapeutic efficacy, and clinical impact across diverse cancer types, as well as the synthesis of novel FAP-targeted ligands. This review aims to showcase the promising outcomes and challenges in integrating FAPtargeted approaches into cancer management. Semin Nucl Med 54:537-556 (c) 2024 Published by Elsevier Inc.

引用

页码：537 / 556

页数：20

共 50 条

[1] Fibroblast Activation Protein Inhibitor Theranostics The Case for Use in Sarcoma
Hamacher, Rainer
Lanzafame, Helena
Mavroeidi, Ilektra A.
Pabst, Kim M.
Kessler, Lukas
Cheung, Phyllis F.
Bauer, Sebastian
Herrmann, Ken
Schildhaus, Hans-Ulrich
Siveke, Jens T.
Fendler, Wolfgang P.
PET CLINICS, 2023, 18 (03) : 361 - 367
[2] Fibroblast Activation Protein Inhibitor Theranostics
Raju, Shobhana
Shukla, Jaya
Kumar, Rakesh
PET CLINICS, 2022, 17 (03) : 453 - 464
[3] Fibroblast activation protein-based theranostics in cancer research: A state-of-the-art review
Zhao, Liang
Chen, Jianhao
Pang, Yizhen
Fu, Kaili
Shang, Qihang
Wu, Hua
Sun, Long
Lin, Qin
Chen, Haojun
THERANOSTICS, 2022, 12 (04): : 1557 - 1569
[4] Theranostics in targeting fibroblast activation protein bearing cells: Progress and challenges
Rezaei, Sahar
Gharapapagh, Esmaeil
Dabiri, Shahram
Heidari, Pedram
Aghanejad, Ayuob
LIFE SCIENCES, 2023, 329
[5] Fibroblast Activation Protein Inhibitor Theranostics: Early Clinical Translation
Mori, Yuriko
Kratochwil, Clemens
Haberkorn, Uwe
Giesel, Frederik L.
PET CLINICS, 2023, 18 (03) : 419 - 428
[6] Fibroblast activation protein-based theranostics in pancreatic cancer
Cheng, Chien-shan
Yang, Pei-wen
Sun, Yun
Song, Shao-li
Chen, Zhen
FRONTIERS IN ONCOLOGY, 2022, 12
[7] Diagnostic and Therapeutic Application of Fibroblast Activation Protein Inhibitors in Oncologic and Nononcologic Diseases
Nakayama, Mariko
Hope, Thomas A.
Salavati, Ali
CANCER JOURNAL, 2024, 30 (03) : 210 - 217
[8] Radioligands Targeting Fibroblast Activation Protein (FAP)
Lindner, Thomas
Giesel, Frederik L.
Kratochwil, Clemens
Serfling, Sebastian E.
CANCERS, 2021, 13 (22)
[9] Selective inhibitors of fibroblast activation protein (FAP) with a xanthine scaffold
Jansen, Koen
De Winter, Hans
Heirbaut, Leen
Cheng, Jonathan D.
Joossens, Jurgen
Lambeir, Anne-Marie
De Meester, Ingrid
Augustyns, Koen
Van der Veken, Pieter
MEDCHEMCOMM, 2014, 5 (11) : 1700 - 1707
[10] Tailoring Fibroblast-Activation Protein Targeting for Theranostics: A Comparative Preclinical Evaluation of the 68Ga- and 177Lu-Labeled Monomeric and Dimeric Fibroblast-Activation Protein Inhibitors DOTA.SA.FAPi and DOTAGA.(SA.FAPi)2
Lappchen, Tilman
Bilinska, Adrianna
Pilatis, Eirinaios
Menendez, Elena
Imlimthan, Surachet
Moon, Euy Sung
Afshar-Oromieh, Ali
Rosch, Frank
Rominger, Axel
Gourni, Eleni
MOLECULES, 2024, 29 (13):

← 1 2 3 4 5 →